Regulation of bile acid metabolism: New insights from inside

Hepatology

Volumn 58, Issue 5, 2013, Pages 1850-1853

  Quintero, Pablo ^a   Arrese, Marco ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; BILE ACID; CHOLESTEROL 7ALPHA MONOOXYGENASE; CHOLIC ACID; CONSTITUTIVE ANDROSTANE RECEPTOR; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR 15; PREGNANE X RECEPTOR; PROTEIN KINASE C; TAUROCHOLIC ACID; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; URSODEOXYCHOLIC ACID; VITAMIN D RECEPTOR;

ANTIBIOTIC THERAPY; ARTICLE; BILE ACID METABOLISM; BROWN ADIPOSE TISSUE; CHEMICAL COMPOSITION; DRUG MEGADOSE; ENTEROHEPATIC CIRCULATION; FAT INTAKE; HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INTESTINE FLORA; LIPID DIET; MICROBIAL METABOLISM; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATION; PRIMARY SCLEROSING CHOLANGITIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; BILE ACIDS AND SALTS; GASTROINTESTINAL TRACT; METAGENOME; RECEPTORS, CYTOPLASMIC AND NUCLEAR; TAUROCHOLIC ACID;

EID: 84887023541     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.26569     Document Type: Article

References (13)

1. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010;90:859-904.
2. Quigley EM, Stanton C, Murphy EF. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatol 2012.
3. Miyake Y, Yamamoto K. Role of gut microbiota in liver diseases. Hepatol Res 2013;43:139-146.
4. Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, et al. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 2013;17:225-235.
5. Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 2009;89:147-191.
6. Watanabe M, Houten SM, Mataki C, Christoffolete MA, Kim BW, Sato H, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484-489.
7. Chiang JY. Bile acids: regulation of synthesis. J Lipid Res 2009;50:1955-1966.
8. Trottier J, Milkiewicz P, Kaeding J, Verreault M, Barbier O. Coordinate regulation of hepatic bile acid oxidation and conjugation by nuclear receptors. Mol Pharm 2006;3:212-222.
9. Wostmann BS. Intestinal bile acids and cholesterol absorption in the germfree rat. J Nutr 1973;103:982-990.
10. Watanabe M, Horai Y, Houten SM, Morimoto K, Sugizaki T, Arita E, et al. Lowering bile acid pool size with a synthetic farnesoid X receptor (FXR) agonist induces obesity and diabetes through reduced energy expenditure. J Biol Chem 2011;286:26913-26920.
11. Marschall HU, Mueller M, Wagner M, Fickert P, Zollner G, Silbert D, et al. High levels of ursodeoxycholic acid act as fxr antagonist and deplete liver cholesterol due to increased bile acid synthesis in morbidly obese patients. J Hepatol 2012;56:S515-S515.
12. Hofmann AF, Hagey LR. Bile acids: chemistry, pathochemistry, biology, pathobiology, and therapeutics. Cell Mol Life Sci 2008;65:2461-2483.
13. Arrese M, Ananthanarayanan M. Mice and men: are they bile-ologically different? Hepatology 2001;33:1551-1553.